{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:59:16Z","timestamp":1792299556894,"version":"4.4.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The present study will highlight recent advances in the field of myoclonus-dystonia with a focus on clinical aspects, pathogenesis, and treatment. We will also discuss genetics, classification issues, and diagnostic criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>\n                      Myoclonus-dystonia is a clinical syndrome corresponding to the phenotype linked to\n                      <jats:italic toggle=\"yes\">SGCE<\/jats:italic>\n                      , the main causative gene. Childhood-onset myoclonus that predominates over dystonia with prominent upper body involvement, an absence of truncal dystonia, associated anxiety or compulsivity, and a positive family history are helpful diagnostic clues. Recent studies demonstrated that zonisamide is an interesting therapeutic option in myoclonus-dystonia, and that bilateral pallidal stimulation has major and lasting therapeutic effects. Accumulating evidence suggests that an alteration in cerebello-thalamic pathway function may play a prominent role and that this is possibly related to a GABAergic deficit reflecting Purkinje cell dysfunction. Impaired striatal plasticity and disturbed serotonin homeostasis may also be implicated. Newly available cellular and rodent models may further assist in investigating the pathogenesis of this disorder.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Comprehensive analysis of the phenotype and precise classification are important in patients with myoclonus and dystonia to identify homogeneous groups of patients. This is critical to guide tailored therapeutic strategies and promote effective research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/wco.0000000000000577","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T19:01:45Z","timestamp":1530039705000},"page":"484-490","source":"Crossref","is-referenced-by-count":104,"title":["Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment"],"prefix":"10.1097","volume":"31","author":[{"given":"Emmanuel","family":"Roze","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, Facult\u00e9 de M\u00e9decine; CNRS UMR 7225, UMR S 1127, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re"},{"name":"APHP, H\u00f4pital Salp\u00eatri\u00e8re, D\u00e9partement de Neurologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[{"name":"Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vidailhet","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Facult\u00e9 de M\u00e9decine; CNRS UMR 7225, UMR S 1127, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re"},{"name":"APHP, H\u00f4pital Salp\u00eatri\u00e8re, D\u00e9partement de Neurologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230925","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/01.wnl.0000297516.98574.c0","article-title":"Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations","volume":"70","author":"Roze","year":"2008","journal-title":"Neurology"},{"key":"R2-20230925","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fneur.2016.00072","article-title":"Distribution and coexistence of myoclonus and dystonia as clinical predictors of SGCE mutation status: a pilot study","volume":"7","author":"Zutt","year":"2016","journal-title":"Front Neurol"},{"key":"R3-20230925","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1007\/s00415-014-7488-3","article-title":"SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype","volume":"261","author":"Peall","year":"2014","journal-title":"J Neurol"},{"key":"R4-20230925","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/mds.25506","article-title":"Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria","volume":"28","author":"Carecchio","year":"2013","journal-title":"Mov Disord"},{"key":"R5-20230925","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5334\/tohm.303","article-title":"Speech-activated myoclonus mimicking stuttering in a patient with myoclonus-dystonia syndrome","volume":"6","author":"Isaacs","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"R6-20230925","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/mds.22273","article-title":"Electrophysiological features of myoclonus-dystonia","volume":"23","author":"Li","year":"2008","journal-title":"Mov Disord"},{"key":"R7-20230925","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ana.25035","article-title":"Alcohol improves cerebellar learning deficit in myoclonus-dystonia: a clinical and electrophysiological investigation","volume":"82","author":"Weissbach","year":"2017","journal-title":"Ann Neurol"},{"key":"R8-20230925","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/brain\/aws308","article-title":"SGCE mutations cause psychiatric disorders: clinical and genetic characterization","volume":"136","author":"Peall","year":"2013","journal-title":"Brain"},{"key":"R9-20230925","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/acn3.263","article-title":"Psychiatric disorders, myoclonus dystonia and SGCE: an international study","volume":"3","author":"Peall","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"R10-20230925","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/jnnp.2010.232793","article-title":"Impaired saccadic adaptation in DYT11 dystonia","volume":"82","author":"Hubsch","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-20230925","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamaneurol.2014.99","article-title":"The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias","volume":"71","author":"Popa","year":"2014","journal-title":"JAMA Neurol"},{"key":"R12-20230925","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e31827f0798","article-title":"Metabolic changes in DYT11 myoclonus-dystonia","volume":"80","author":"Carbon","year":"2013","journal-title":"Neurology"},{"key":"R13-20230925","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/mds.25128","article-title":"White matter abnormalities in gene-positive myoclonus-dystonia","volume":"27","author":"van der Meer","year":"2012","journal-title":"Mov Disord"},{"key":"R14-20230925","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/mds.26244","article-title":"Pallidal activity in myoclonus dystonia correlates with motor signs","volume":"30","author":"Welter","year":"2015","journal-title":"Mov Disord"},{"key":"R15-20230925","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mds.21284","article-title":"Local field potentials and oscillatory activity of the internal globus pallidus in myoclonus-dystonia","volume":"22","author":"Foncke","year":"2007","journal-title":"Mov Disord"},{"key":"R16-20230925","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2017.08.007","article-title":"Abnormal striatal plasticity in a DYT11\/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition","volume":"108","author":"Maltese","year":"2017","journal-title":"Neurobiol Dis"},{"key":"R17-20230925","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archneurol.2010.54","article-title":"Disorganized sensorimotor integration in mutation-positive myoclonus-dystonia: a functional magnetic resonance imaging study","volume":"67","author":"Beukers","year":"2010","journal-title":"Arch Neurol"},{"key":"R18-20230925","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/mds.21519","article-title":"Abnormal low frequency drive in myoclonus-dystonia patients correlates with presence of dystonia","volume":"22","author":"Foncke","year":"2007","journal-title":"Mov Disord"},{"key":"R19-20230925","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/mds.27117","article-title":"Low CSF 5-HIAA in myoclonus dystonia","volume":"32","author":"Peall","year":"2017","journal-title":"Mov Disord"},{"key":"R20-20230925","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jb\/mvj138","article-title":"Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice","volume":"140","author":"Yokoi","year":"2006","journal-title":"J Biochem"},{"key":"R21-20230925","doi-asserted-by":"crossref","first-page":"e33669","DOI":"10.1371\/journal.pone.0033669","article-title":"Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"R22-20230925","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00259-008-0924-9","article-title":"Reduced striatal D2 receptor binding in myoclonus-dystonia","volume":"36","author":"Beukers","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-20230925","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/mds.27123","article-title":"It's not just the basal ganglia: cerebellum as a target for dystonia therapeutics","volume":"32","author":"Tewari","year":"2017","journal-title":"Mov Disord"},{"key":"R24-20230925","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nbd.2016.11.003","article-title":"Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome","volume":"98","author":"Xiao","year":"2017","journal-title":"Neurobiol Dis"},{"key":"R25-20230925","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/WNL.0000000000002631","article-title":"A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia","volume":"86","author":"Hainque","year":"2016","journal-title":"Neurology"},{"key":"R26-20230925","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.parkreldis.2014.09.029","article-title":"Treatment of myoclonus-dystonia syndrome with tetrabenazine","volume":"20","author":"Luciano","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"R27-20230925","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.25326","article-title":"Surgical treatment of myoclonus dystonia syndrome","volume":"28","author":"Rughani","year":"2013","journal-title":"Mov Disord"},{"key":"R28-20230925","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.26215","article-title":"Pallidal stimulation for myoclonus-dystonia: ten years\u2019 outcome in two patients","volume":"30","author":"Roze","year":"2015","journal-title":"Mov Disord"},{"key":"R29-20230925","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/humu.9521","article-title":"Myoclonus-dystonia: significance of large SGCE deletions","volume":"29","author":"Grunewald","year":"2008","journal-title":"Hum Mutat"},{"key":"R30-20230925","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/mds.26738","article-title":"Myoclonus dystonia and muscular dystrophy: epsilon-sarcoglycan is part of the dystrophin-associated protein complex in brain","volume":"31","author":"Waite","year":"2016","journal-title":"Mov Disord"},{"key":"R31-20230925","doi-asserted-by":"crossref","first-page":"41156","DOI":"10.1038\/srep41156","article-title":"Faithful SGCE imprinting in iPSC-derived cortical neurons: an endogenous cellular model of myoclonus-dystonia","volume":"7","author":"Grutz","year":"2017","journal-title":"Sci Rep"},{"key":"R32-20230925","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archneur.65.10.1380","article-title":"Myoclonus-dystonia due to maternal uniparental disomy","volume":"65","author":"Guettard","year":"2008","journal-title":"Arch Neurol"},{"key":"R33-20230925","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10048-017-0510-z","article-title":"ADCY5-related dyskinesia presenting as familial myoclonus-dystonia","volume":"18","author":"Douglas","year":"2017","journal-title":"Neurogenetics"},{"key":"R34-20230925","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ajhg.2015.04.008","article-title":"A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia","volume":"96","author":"Mencacci","year":"2015","journal-title":"Am J Hum Genet"},{"key":"R35-20230925","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/hmg\/ddu513","article-title":"CACNA1B mutation is linked to unique myoclonus-dystonia syndrome","volume":"24","author":"Groen","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R36-20230925","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/mds.26070","article-title":"RELN rare variants in myoclonus-dystonia","volume":"30","author":"Groen","year":"2015","journal-title":"Mov Disord"},{"key":"R37-20230925","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.0b013e318261714a","article-title":"Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency","volume":"79","author":"Stamelou","year":"2012","journal-title":"Neurology"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00019052-201808000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T07:55:44Z","timestamp":1695628544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-201808000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0000000000000577","relation":{},"ISSN":["1350-7540","1473-6551"],"issn-type":[{"value":"1350-7540","type":"print"},{"value":"1473-6551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}